CPT1A gene expression was also unexpectedly reduced, similar to what has been observed in human NASH [28], [32], possibly due to excessive accumulation of malonyl-CoA in advanced NASH. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatohepatitis.